Distress and Wellbeing among General Practitioners in 33 Countries during COVID-19: Results from the Cross-Sectional PRICOV-19 Study to Inform Health System Interventions.

COVID-19 distress general practice/family medicine health system interventions organizational wellbeing

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
06 05 2022
Historique:
received: 23 03 2022
revised: 29 04 2022
accepted: 03 05 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

Emerging literature is highlighting the huge toll of the COVID-19 pandemic on frontline health workers. However, prior to the crisis, the wellbeing of this group was already of concern. The aim of this paper is to describe the frequency of distress and wellbeing, measured by the expanded 9-item Mayo Clinic Wellbeing Index (eWBI), among general practitioners/family physicians during the COVID-19 pandemic and to identify levers to mitigate the risk of distress. Data were collected by means of an online self-reported questionnaire among GP practices. Statistical analysis was performed using SPSS software using Version 7 of the database, which consisted of the cleaned data of 33 countries available as of 3 November 2021. Data from 3711 respondents were included. eWBI scores ranged from -2 to 9, with a median of 3. Using a cutoff of ≥2, 64.5% of respondents were considered at risk of distress. GPs with less experience, in smaller practices, and with more vulnerable patient populations were at a higher risk of distress. Significant differences in wellbeing scores were noted between countries. Collaboration from other practices and perception of having adequate governmental support were significant protective factors for distress. It is necessary to address practice- and system-level organizational factors in order to enhance wellbeing and support primary care physicians.

Identifiants

pubmed: 35565070
pii: ijerph19095675
doi: 10.3390/ijerph19095675
pmc: PMC9101443
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

BMJ Open. 2013 Apr 11;3(4):
pubmed: 23585394
Br J Gen Pract. 2016 Jul;66(648):e507-15
pubmed: 27162205
J Am Med Dir Assoc. 2021 Feb;22(2):238-244.e1
pubmed: 33238143
BMC Fam Pract. 2020 May 16;21(1):88
pubmed: 32416714
Ir J Med Sci. 2022 Feb;191(1):93-96
pubmed: 33660115
Span J Psychol. 2015 Sep 14;18:E64
pubmed: 26364645
Cochrane Database Syst Rev. 2020 Nov 5;11:CD013779
pubmed: 33150970
Front Public Health. 2021 Feb 03;9:623904
pubmed: 33614587
BMC Public Health. 2021 Jan 9;21(1):104
pubmed: 33422039
Health Policy. 2013 Dec;113(3):258-69
pubmed: 24095274
Br J Gen Pract. 2018 Dec;68(677):e819-e825
pubmed: 30297436
Brain Behav Immun Health. 2020 Oct;8:100144
pubmed: 32959031
Br J Gen Pract. 2022 Apr 28;72(718):e325-e333
pubmed: 35314428
BMC Fam Pract. 2016 Mar 24;17:36
pubmed: 27009060
BMJ Open. 2020 May 12;10(5):e029846
pubmed: 32404383
PLoS One. 2021 Jun 18;16(6):e0253447
pubmed: 34143849
Int J Environ Res Public Health. 2020 Dec 05;17(23):
pubmed: 33291511
BMJ Open. 2020 Jun 17;10(6):e039674
pubmed: 32554730
Eur J Gen Pract. 2021 Dec;27(1):277-285
pubmed: 34633272
BMJ Open. 2021 Aug 18;11(8):e046599
pubmed: 34408036
BMC Prim Care. 2022 Jan 15;23(1):11
pubmed: 35172744
BJGP Open. 2021 Aug 24;5(4):
pubmed: 34172477
Int J Environ Res Public Health. 2021 Feb 21;18(4):
pubmed: 33669982
Fam Pract. 2022 Jan 19;39(1):65-73
pubmed: 34482406
Lancet. 2016 Nov 5;388(10057):2272-2281
pubmed: 27692469
Psychiatry Res. 2020 Nov;293:113441
pubmed: 32898840
Medicina (Kaunas). 2021 Dec 18;57(12):
pubmed: 34946326
Br J Gen Pract. 1992 Apr;42(357):153-6
pubmed: 1586551
J Investig Med. 2020 Oct;68(7):1228-1234
pubmed: 32747387
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Interprof Care. 2020 Sep-Oct;34(5):672-678
pubmed: 32962462
J Affect Disord. 2020 Dec 1;277:347-357
pubmed: 32861835
BMC Health Serv Res. 2021 Sep 6;21(1):923
pubmed: 34488733
J Occup Environ Med. 2016 Aug;58(8):810-7
pubmed: 27294444
Acta Biomed. 2020 May 11;91(2):83-88
pubmed: 32420931
BJPsych Bull. 2021 Apr;45(2):93-97
pubmed: 32340645

Auteurs

Claire Collins (C)

Research Centre, Irish College of General Practitioners, D02 XR68 Dublin, Ireland.

Els Clays (E)

Department of Public Health and Primary Care, Ghent University, 9000 Ghent, Belgium.

Esther Van Poel (E)

Department of Public Health and Primary Care, Ghent University, 9000 Ghent, Belgium.

Joanna Cholewa (J)

Institute of Health and Society, Catholic University of Louvain, 1348 Louvain-la-Neuve, Belgium.

Katica Tripkovic (K)

City Institute of Public Health Belgrade, 11000 Belgrade, Serbia.

Katarzyna Nessler (K)

Department of Family Medicine, Jagiellonian University Medical College, 31-061 Krakow, Poland.

Ségolène de Rouffignac (S)

Institute of Health and Society, Catholic University of Louvain, 1348 Louvain-la-Neuve, Belgium.

Milena Šantrić Milićević (M)

Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

Zoran Bukumiric (Z)

Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

Limor Adler (L)

Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Cécile Ponsar (C)

Institute of Health and Society, Catholic University of Louvain, 1348 Louvain-la-Neuve, Belgium.

Liubove Murauskiene (L)

Public Health Department, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania.

Zlata Ožvačić Adžić (Z)

Department of Family Medicine, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

Adam Windak (A)

Department of Family Medicine, Jagiellonian University Medical College, 31-061 Krakow, Poland.

Radost Asenova (R)

Department of General Practice, Medical University Plovdiv, 4003 Plovdiv, Bulgaria.

Sara Willems (S)

Department of Public Health and Primary Care, Ghent University, 9000 Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH